Misc. news stories

Psychedelic businesses have an opportunity to disrupt existing paradigms with regenerative economic practices. The question is: will they take it?

A study suggests that psychedelics can access receptors inside cells that standard antidepressants usually can’t affect.

A Nasdaq-listed company is trialling the active ingredient in magic mushrooms as a new treatment.

It is as if the human body has its own version of a marijuana seedling inside, constantly producing small amounts of endocannabinoids.

The results from the first randomized, double-blind, placebo-controlled study to systematically investigate the effects of psilocybin in cluster headache has been published in the scientific journal Headache. The initial study provides useful information for creating bigger and more conclusive studies in the future.

Psychedelics go beneath the cell surface to unleash their potentially therapeutic effects.

In the span of 15 years, psychedelics have transformed dramatically in the public eye, from the consciousness-expanding darlings of the counterculture to what could be the most significant breakthrough in psychiatric treatment in many decades.

Image from: Pashminu (Wiki Commons)

The use of psilocybin, a hallucinogenic substance found in some “magic” mushrooms, has stronger connection to how people feel about nature compared to the use of other psychedelic drugs, according to new research published in the Journal of Psychopharmacology.

A study published in BJ Psych Open suggests that psilocybin, a psychedelic substance found in “magic” mushrooms, may be more beneficial than certain antidepressants for helping improve depressive symptoms related to thought suppression and rumination.

Many are celebrating Australia’s decision to pave the way for these psychedelic therapies, but questions around accessibility remain.

Image from: Pashminu (Wiki Commons)

Psychedelic medicines have shown great promise in treating mental health conditions and helping patients see life from a new perspective, but their benefits may go even further in repairing injuries to the brain and, therefore, consciousness itself.

A new study published in the Journal of Psychopharmacology is the first to characterize the psychological impacts of psilocybin among people with bipolar disorder.

Undergoing a brush with death may sound terrifying. But people who have had a near-death experience (NDE) typically report feeling peace, comfort, and calm throughout the ordeal.

Melanie Senn’s father, long dead, appeared to her as she lay back in the dimly lit room at the Santa Monica clinic, a mask over her closed eyes, and the psychedelic trip began.

Image from: Imperial College London (Wiki Commons)

A single dose of the psychedelic drug psilocybin combined with supportive counseling leads to significant reductions in depressive symptoms, according to a new double-blind, placebo-controlled study. The findings have recently been published in eClinicalMedicine.

Image from: Cannabis Picture (Wiki Commons)

A study has taken a look at the real-life experiences of people using N,N-Dimethyltryptamine, more commonly referred to as DMT.